pyrazolanthrone has been researched along with Cardiovascular Diseases in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Reddy, PA; Siddiqui, MA | 1 |
Damdindorj, L; Hosokawa, Y; Hossain, E; Karnan, S; Konishi, H; Konishi, Y; Ota, A; Takahashi, M | 1 |
2 other study(ies) available for pyrazolanthrone and Cardiovascular Diseases
Article | Year |
---|---|
Small molecule JNK (c-Jun N-terminal kinase) inhibitors.
Topics: Allosteric Regulation; Animals; Cardiovascular Diseases; Crystallography, X-Ray; Humans; Inflammation; Isoenzymes; JNK Mitogen-Activated Protein Kinases; Metabolic Diseases; Neurodegenerative Diseases; Protein Conformation; Protein Kinase Inhibitors; Signal Transduction | 2010 |
Arsenic upregulates the expression of angiotensin II Type I receptor in mouse aortic endothelial cells.
Topics: Acetylcysteine; Animals; Anthracenes; Aorta; Arsenites; Cardiovascular Diseases; Cell Line; Cell Proliferation; Endothelium, Vascular; Environmental Pollutants; Enzyme Inhibitors; Free Radical Scavengers; Mice; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Sodium Compounds; Up-Regulation | 2013 |